These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
308 related items for PubMed ID: 8794987
1. Pharmacokinetic and pharmacodynamic properties of FK070 (KDI-792), a novel thromboxane receptor antagonist/thromboxane synthetase inhibitor, after single and multiple oral administrations to healthy volunteers. Uematsu T, Kosuge K, Umemura K, Nakano M, Terakawa M, Nakashima M. J Pharm Pharmacol; 1996 Apr; 48(4):380-5. PubMed ID: 8794987 [Abstract] [Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic profiles of vapiprost, a selective, long-lasting thromboxane receptor antagonist, after single and multiple oral administration to healthy volunteers. Uematsu T, Nagashima S, Mizuno A, Hirano K, Nakashima M. J Clin Pharmacol; 1991 Sep; 31(9):815-22. PubMed ID: 1839540 [Abstract] [Full Text] [Related]
6. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets. Ohkubo S, Nakahata N, Ohizumi Y. Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602 [Abstract] [Full Text] [Related]
7. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids. Cozzi P, Giordani A, Menichincheri M, Pillan A, Pinciroli V, Rossi A, Tonani R, Volpi D, Tamburin M, Ferrario R. J Med Chem; 1994 Oct 14; 37(21):3588-604. PubMed ID: 7932586 [Abstract] [Full Text] [Related]
8. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung. Bureau MF, De Clerck F, Lefort J, Arreto CD, Vargaftig BB. J Pharmacol Exp Ther; 1992 Feb 14; 260(2):832-40. PubMed ID: 1738127 [Abstract] [Full Text] [Related]
14. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets. Vezza R, Mezzasoma AM, Venditti G, Gresele P. Thromb Haemost; 2002 Jan 03; 87(1):114-21. PubMed ID: 11848439 [Abstract] [Full Text] [Related]
15. Phase I study of Y-20811, a new long-acting thromboxane synthetase inhibitor by oral administration. Nakashima M, Uematsu T, Takiguchi Y, Mizuno A, Kanamaru M. J Clin Pharmacol; 1989 Jun 03; 29(6):568-76. PubMed ID: 2754025 [Abstract] [Full Text] [Related]